Grufity logo
Grufity logo

Latest venBio Partners LLC Stock Portfolio

$280Million | No. of Holdings #6

venBio Partners LLC Performance

2026 Q1+27.74%
YTD+27.74%
2025+26.25%

About venBio Partners LLC and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, venBio Partners LLC reported an equity portfolio of $280.6 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of venBio Partners LLC are PHVS, , ALXO. The fund has invested 46.7% of it's portfolio in PHARVARIS N V and 35.6% of portfolio in ALUMIS INC. <br><br> They significantly reduced their stock positions in ARTIVA BIOTHERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to ALX ONCOLOGY HLDGS INC (ALXO).
venBio Partners LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$280Million
  as of May 15, 2026

venBio Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that venBio Partners LLC made a return of 27.74% in the last quarter. In trailing 12 months, it's portfolio return was 116.18%.
  • Performance
  • S&P 500

New Buys

No new stocks were added by venBio Partners LLC

Additions

Ticker% Inc.
alx oncology hldgs inc32.83
Additions to existing portfolio by venBio Partners LLC

Reductions

Ticker% Reduced
artiva biotherapeutics inc-18.07
alumis inc-1.98
venBio Partners LLC reduced stake in above stock

Sold off

None of the stocks were completely sold off by venBio Partners LLC

Sector Distribution

venBio Partners LLC has about 83.5% of it's holdings in Others sector.

  • Others
  • Healthcare
Sector%
Others83.5
Healthcare16.5

Market Cap. Distribution

venBio Partners LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MICRO-CAP
  • MID-CAP
  • SMALL-CAP
Category%
UNALLOCATED83.5
MICRO-CAP9.2
MID-CAP4.9
SMALL-CAP2.4

Stocks belong to which Index?

About 16.5% of the stocks held by venBio Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others83.5
RUSSELL 200016.5
Top 5 Winners (%)%
alumis inc
124.5 %
ALXO
alx oncology hldgs inc
61.9 %
artiva biotherapeutics inc
45.6 %
PHVS
pharvaris n v
1.8 %
Top 5 Winners ($)$
alumis inc
56.1 M
ALXO
alx oncology hldgs inc
9.9 M
PHVS
pharvaris n v
2.3 M
artiva biotherapeutics inc
1.3 M
Top 5 Losers (%)%
LYEL
lyell immunopharma inc
-34.8 %
HRMY
harmony biosciences hldgs in
-25.1 %
Top 5 Losers ($)$
HRMY
harmony biosciences hldgs in
-4.6 M
LYEL
lyell immunopharma inc
-3.6 M

venBio Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of venBio Partners LLC

venBio Partners LLC has 6 stocks in it's portfolio. HRMY proved to be the most loss making stock for the portfolio. was the most profitable stock for venBio Partners LLC last quarter.

$280.55MTotal Value
6.00Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of venBio Partners LLC, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
PHVS
Pharvaris N V

Pharvaris N V

PHVS
venBio Partners LLC's holding in Pharvaris N V over time
46.72%4,639,300
$131.06M
46.72%
unchanged 0 percentunchanged
Com
Alumis Inc

Alumis Inc

venBio Partners LLC's holding in Alumis Inc over time
35.56%4,528,410
$99.76M
35.56%
decreased 1.98 percentreduced
Com
Artiva Biotherapeutics Inc

Artiva Biotherapeutics Inc

venBio Partners LLC's holding in Artiva Biotherapeutics Inc over time
1.22%531,337
$3.42M
1.22%
decreased 18.07 percentreduced